Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Friedemann Kimmich"'
Publikováno v:
Clinical Ophthalmology, Vol 2009, Iss default, Pp 33-39 (2008)
Thomas Kaercher1, Patricia Buchholz2, Friedemann Kimmich31Augenarztpraxis, Heidelberg, Germany; 2Allergan Europe, Ettlingen, Germany; 3Eyecons, Pfinztal, GermanyObjective: To evaluate the efficacy and tolerability of OptiveTM, a new dry eye product c
Externí odkaz:
https://doaj.org/article/63120919cba7403bafb0e8d7c707075d
Autor:
Uwe Pleyer, C. Jacobi, Gerd Geerling, Stefan Schrader, Friedemann Kimmich, Elisabeth M. Messmer
Publikováno v:
Klinische Monatsblätter für Augenheilkunde. 237:655-668
ZusammenfassungDas Trockene Auge stellt eine heterogene Erkrankung der Augenoberfläche dar. Das Krankheitsbild hat multifaktorielle Ursachen und geht normalerweise mit einer Erhöhung der Osmolarität des Tränenfilms und mit Entzündungsprozessen d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73eb745f235888022d458979b177f694
https://doi.org/10.1055/a-1115-4756
https://doi.org/10.1055/a-1115-4756
Autor:
Uwe, Pleyer, Gerd, Geerling, Stefan, Schrader, Christina, Jacobi, Friedemann, Kimmich, Elisabeth, Messmer
Publikováno v:
Klinische Monatsblatter fur Augenheilkunde. 237(5)
Dry eye disease (DED) is a heterogenous disease of the ocular surface. Multiple pathogenetic factors are responsible for the disease process, but DED is generally linked to an increase in the osmolarity of the tear film and to inflammation of the ocu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77c6730d0acf1cc4c3222b9c67ee1c29
https://pubmed.ncbi.nlm.nih.gov/32434249
https://pubmed.ncbi.nlm.nih.gov/32434249
Publikováno v:
Clinical Ophthalmology. 11:1583-1600
Over the last decade several novel surgical treatment options and devices for glaucoma have been developed. All these developments aim to cause as little trauma as possible to the eye, to safely, effectively, and sustainably reduce intraocular pressu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::99c13a0da3bea52317fadccf245c9c79
https://doi.org/10.2147/opth.s135316
https://doi.org/10.2147/opth.s135316
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Lutz E Pillunat,1 Carl Erb,2 Auli Ropo,3 Friedemann Kimmich,4 Norbert Pfeiffer5 1Department of Ophthalmology, University Hospital Carl Gustav Carus, Dresden, 2Augenklinik am Wittenbergplatz, Berlin, Germany; 3Santen Europe, Helsinki, Finland; 4eyecon
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::494a001b74af446caecaca9a53dc3b17
http://europepmc.org/articles/PMC5472425
http://europepmc.org/articles/PMC5472425
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Over the last decade several novel surgical treatment options and devices for glaucoma have been developed. All these developments aim to cause as little trauma as possible to the eye, to safely, effectively, and sustainably reduce intraocular pressu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::18947affbbf14a7a326d0d4aa1ddbfa5
https://www.dovepress.com/corrigendum-micro-invasive-glaucoma-surgery-migs-a-review-of-surg-peer-reviewed-article-OPTH
https://www.dovepress.com/corrigendum-micro-invasive-glaucoma-surgery-migs-a-review-of-surg-peer-reviewed-article-OPTH
Autor:
Klaus Rosbach, Ines Lanzl, Thomas Hamacher, Robert Rothe, Mohammed Osman Ramez, Marta Karhanová, Friedemann Kimmich, Eva Růžičková
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Ines Lanzl,1 Thomas Hamacher,2 Klaus Rosbach,3 Mohammed Osman Ramez,4 Robert Rothe,5 Eva Ružicková,6 Marta Karhanová,7 Friedemann Kimmich81Private practice, Prien, Germany; 2Private practice, Starnberg, Germany; 3Private practice, Mainz, Germany
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::78fbc089caa8a136b4caf9043db61813
http://europepmc.org/articles/PMC3663435
http://europepmc.org/articles/PMC3663435
Autor:
Anton Hommer, Friedemann Kimmich
Publikováno v:
Clinical Ophthalmology (Auckland, N.Z.)
Anton Hommer¹, Friedemann Kimmich²¹Sanatorium Hera, Vienna, Austria; ²eyecons, Pfinztal, GermanyPurpose: Efficacy, tolerability and safety of the novel preservative-free prostaglandin tafluprost 0.0015% were investigated for the treatment of pati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88005224f8d27590e0421bcacfe742a5
http://europepmc.org/articles/PMC3104790
http://europepmc.org/articles/PMC3104790
Publikováno v:
Current Medical Research and Opinion. 25:1003-1009
At the introduction of the fixed-combination of brimonidine/timolol in Germany in 2006, a non-interventional, multicenter, observational, open-label study was initiated to evaluate efficacy, tolerability, and safety of this preparation in a broad pat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::765b5dfa77c15ecc1cf26f0a05a59677
https://doi.org/10.1185/03007990902805916
https://doi.org/10.1185/03007990902805916
Publikováno v:
Ophthalmologica. 208:32-36
In a 3-month, double-masked, randomized clinical trial, the ocular hypotensive efficacy and systemic safety of 0.5% levobunolol and 2% carteolol were compared in 59 patients with open-angle glaucoma or ocular hypertension. The overall mean decrease i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da2faf508e6a0d845148d803124ee6ad
https://doi.org/10.1159/000310446
https://doi.org/10.1159/000310446